Sleiman, Joseph, Aline Charabaty, and Asad ur Rahman. “Do Pharmacokinetics Justify Dose-Optimization for Loss of Response to Vedolizumab in IBD?”. @Gijournal 1, no. 1 (August 31, 2021). Accessed September 11, 2026. https://gijournal.org/index.php/gijournal/article/view/23.